Collaborative Journalism Congressional Scrutiny Intensifies: Senator Hassan Challenges Merck Over Keytruda Patent Strategies July 21, 2026 rifanmuazin In a high-stakes escalation of the ongoing battle over American healthcare affordability, U.S. Senator Maggie Hassan (D-N.H.) has launched a formal inquiry into pharmaceutical giant Merck & Co., demanding accountability…
Collaborative Journalism Senate Scrutiny Intensifies: The Battle Over Keytruda, Patent "Gimmicks," and the Future of Cancer Care June 30, 2026 Ammar Sabilarrohman In a significant escalation of congressional oversight regarding the pharmaceutical industry’s pricing strategies, U.S. Senator Maggie Hassan (D-N.H.) has launched a pointed inquiry into Merck & Co., demanding accountability for…
